Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine (PR Newswire)

PR Newswire: Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine. “Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to: * Expand the use of a single booster dose to include use in individuals 12 through 15 years of age. * Shorten the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 Vaccine and a booster dose to at least five months. * Allow for a third primary series dose for certain immunocompromised children 5 through 11 years of age.”

Leave a Reply

%d bloggers like this: